Short Interest in Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Decreases By 34.8%
Aclaris Therapeutics, Inc. (NASDAQ:ACRS – Get Free Report) was the recipient of a large decrease in short interest during the month of April. As of April 15th, there was short interest totalling 4,070,000 shares, a decrease of 34.8% from the March 31st total of 6,240,000 shares. Currently, 6.1% of the shares of the stock are […]
